References
- Arya P, Pathak K. 2014. Assessing the viability of microsponges as gastro retentive drug delivery system of curcumin: optimization and pharmacokinetics. Int J Pharm. 460:1–12.
- Box GEP, Behnken DW. 1960. Some new three-level designs for the study of quantitative variables. Technometrics. 2:455–475.
- Celia C, Cilurro F, Trapasso E, Cosco D, Fresta M, Paolino D. 2012. Ethosomes and transferosomes containing linoleic acid: Physicochemical and technological features of topical drug delivery carriers for potential treatment of melasma disorder. BioMed Micro Devices. 14:119–130.
- Cevc G, Schatzlein A, Blume G. 1995. Transdermal drug carrier: basic properties, optimization and transfer efficiency in the case of epicutaneously applied peptide. J Control Release. 36:3–16.
- Cevc G, Mazgareanu S, Rother M, Vierl U. 2008. Occlusion effect on transcutaneous NSAID delivery from conventional and carrier-based formulations. Int J Pharm. 359:190–197.
- Dittmer DP, Richards KL, Damania B. 2012. Treatment of Kaposi sarcoma-associated herpesvirus-associated cancers. Front Microbiol. 3:1–8.
- Douglas JL, Gustin JK, Moses AV, Dezube BJ, Pantanowitz L. 2010. Kaposi Sarcoma pathogenesis: a triad of viral infection, oncogenesis and chronic inflammation. Transl Biomed. 1:172.
- Duangjit S, Opanasopit P, Rojanarata T, Ngawhirunpat T. 2011. Characterization and in vitro skin permeation of meloxicam loaded liposomes versus transfersomes. J Drug Deliv. Article ID 418316.
- El Zaafarany GM, Awad ASG, Holayel SM, Mortada DN. 2010. Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int J Pharm. 397:164–172.
- Ferreira SLC, Bruns RE, Ferreira HS, Matos GD, David JM, Brandao GC, et al. 2007. Box–Behnken design: an alternative for the optimization of analytical methods. Anal Chim Acta. 597:179–186.
- Ghanbarzadeh S, Arami S. 2013. Enhanced transdermal delivery of diclofenac sodium via conventional liposomes, ethosomes and transferosomes. BioMed Res Int. Article ID: 616810.
- Gompper G, Kroll DM. 1995. Driven transport of fluid vesicles through narrow pores. Phys Rev. 52:4198–4208.
- Govender S, Pillay V, Chetty DJ, Essack SY, Dangor CM, Govender T. 2005. Optimization and characterization of bioadhesive controlled release tetracycline microspheres. Int J Pharm. 306:24–40.
- Hennenfent KL, Govindan R. 2006. Novel formulations of taxanes: a review. Old wine in a new bottle? Ann Oncol. 17:735–749.
- Hiruta Y, Hattori Y, Kawano K, Obata Y, Maitani Y. 2006. Novel ultradeformable vesicles entrapped with bleomycin and enhanced to penetrate in the rat skin. J Control Release. 113:146–154.
- Khajeh M. 2009. Application of Box-Behnken design in the optimization of a magnetic nanoparticle procedure for zinc determination in analytical samples by inductively coupled plasma optical emission spectrometry. J Hazard Mater. 172:385–389.
- Kumar A, Pathak K, Bali V. 2012. Ultra-adaptable nanovesicular systems: a carrier for systemic delivery of therapeutic agents. Drug Discovery Today. 17:1233–1241.
- Luo C, Wang Y, Chen Q, Han X, Liu X, Sun J, He Z. 2012. Advances of paclitaxel formulations based on nanosystem delivery technology. Mini Rev Med Chem. 12:434–444.
- Nehate C, Jain S, Saneja A, Khare V, Alam N, Dubey RD, Gupta PN. 2014. Paclitaxel formulations: Challenges and novel delivery options. Curr Drug Deliv. 11:666–686.
- Oostendorp RL, Buckle T, Lambert G, Garrigue JS, Beijnen JH, Schellens JHM, van Tellingen O. 2011. Paclitaxel in self-micro emulsifying formulations: oral bioavailability study in mice. Invest New Drugs. 29:768–776.
- Parsegian VA, Fuller N, Rand RP. 1979. Measured work of deformation and repulsion of lecithin bilayers. Proc Natl Acad Sci USA. 6:2750–2754.
- Raimundo KP, Asche CV. 2011. A review of the efficacy and outcomes studies of currently approved chemotherapy treatments for advanced AIDS-Kaposi’s sarcoma. HIV AIDS Rev. 10:56–60.
- Schatzlein A, Cevc G. 1995. Non-uniform cellular packing of the stratum corneum and permeability barrier function of intact skin: a high resolution confocal laser scanning microscopy study using highly deformable vesicles (Transfersomes). Br J Dermatol. 138:583–592.
- Singla AK, Garg A, Aggarwal D. 2002. Paclitaxel and its formulations. Int J Pharm. 235:179–192.
- Singh B, Kumar R, Ahuja N. 2004. Optimizing drug delivery systems using systematic “Design of Experiments.” Part I: Fundamental aspects. Crit Rev Ther Drug Carr Syst. 22:27–105.
- Sinico C, Manconi M, Peppi LF, Valenti D, Fadda AM. 2005. Liposomes as carrier for dermal delivery of tretinoin: In vitro evaluation of drug permeation and vesicle skin interaction. J Control Release. 103:123–136.
- Toropainen E, Ranta VP, Talvitie A, Suhonen P, Vrtti A. 2001. Culture model of human corneal epithelium for prediction of ocular drug absorption. Invest Ophthalmol Visual Sci. 42:2942–2948.
- Van Asperen J, Van Tellingen O, Van der Valk MA. 1998. Enhanced oral absorption and decreased elimination of paclitaxel in mice cotreated with cyclosporine A. Clin Cancer Res. 4:2293–2297.
- Verma P, Pathak K. 2012. Nanosized ethanolic vesicles loaded with econazole nitrate for the treatment of deep skin infections through topical gel formulation. Nanomed Nanotech Biol Med. 8:489–496.
- Wissing SA, Lippacher A, Muller RH. 2001. Investigations on the occlusive properties of solid lipid nanoparticles (SLN). J Cosmet Sci. 52:313–324.
- Yusuf M, Sharma V, Pathak K. 2014. Nanovesicles for transdermal delivery of felodipine: development, characterization and pharmacokinetics. Int J Pharm Invest. 4:119–130.